Cargando…
Temozolomide in aggressive pituitary adenomas and carcinomas
Temozolomide is an alkylating agent used in the treatment of gliomas and, more recently, aggressive pituitary adenomas and carcinomas. Temozolomide methylates DNA and, thereby, has antitumor effects. O(6)-methylguanine-DNA methyltransferase, a DNA repair enzyme, removes the alkylating adducts that a...
Autores principales: | Ortiz, Leon D., Syro, Luis V., Scheithauer, Bernd W., Rotondo, Fabio, Uribe, Humberto, Fadul, Camilo E., Horvath, Eva, Kovacs, Kalman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328813/ https://www.ncbi.nlm.nih.gov/pubmed/22584716 http://dx.doi.org/10.6061/clinics/2012(Sup01)20 |
Ejemplares similares
-
Pituitary tumors in patients with MEN1 syndrome
por: Syro, Luis V., et al.
Publicado: (2012) -
Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
por: Syro, Luis V., et al.
Publicado: (2018) -
Neurocysticercosis, Meningioma, and Silent Corticotroph Pituitary Adenoma in a 61-Year-Old Woman
por: Ramirez, Maria del Pilar, et al.
Publicado: (2012) -
Progress in the Diagnosis and Classification of Pituitary Adenomas
por: Syro, Luis V., et al.
Publicado: (2015) -
Effect of ASA on pituitary adenomas: is it a matter of survivin?
por: Rotondo, Fabio, et al.
Publicado: (2019)